Related content

Anorectal Carcinoma After Infliximab Therapy in Crohn’s Disease: Report of a Case

By Melichar Bohuslav   Bureš Jan   Dědič Karel  

Diseases of the Colon & Rectum, Vol. 49, Iss. 8, 2006-08 ,pp. : 1228-1233

Springer Publishing Company

Access to resources Recommend Favorite

Recurrent Drug-Induced ANCA Vasculitis in a Patient with Crohn’s Colitis Treated with Infliximab: A Potential Contraindication to Immunosuppressive Therapy

By Rosen David R.   Cologne Kyle G.   Popek Sarah M.   Sung Brian C.   Ortega Adrian E.   Senagore Anthony J.  

The American Surgeon, Vol. 78, Iss. 12, 2012-12 ,pp. : 1406-1408

Southeastern Surgical Congress

Access to resources Recommend Favorite

Surgical management of entero- and colocutaneous fistulae in Crohn’s disease

By Schürmann G.  

International Journal of Colorectal Disease, Vol. 19, Iss. 5, 2004-09 ,pp. : 486-486

Springer Publishing Company

Access to resources Recommend Favorite

Fistulating Anal Crohn’s Disease: Results of Combined Surgical and Infliximab Treatment

By Hyder Syed   Travis Simon   Jewell Derek   Mortensen Neil   George Bruce  

Diseases of the Colon & Rectum, Vol. 49, Iss. 12, 2006-12 ,pp. : 1837-1841

Springer Publishing Company

Access to resources Recommend Favorite

Surgical management of entero and colocutaneous fistulae in Crohn’s disease: 17 year’s experience

By Poritz Lisa   Gagliano G.   McLeod Robin   MacRae Helen   Cohen Zane  

International Journal of Colorectal Disease, Vol. 19, Iss. 5, 2004-09 ,pp. : 481-485

Springer Publishing Company

Access to resources Recommend Favorite